Skip to main content

Regulators, researchers, and clinical practitioners have all been exploring how to best evaluate the different phases of the health AI deployment lifecycle.

The American Medical Informatics Association (AMIA) as the world's largest professional society for medical informaticists has been taking an active role in helping the community identify oversight mechanisms to ensure the safe, effective use of artificial intelligence (AI) applications in healthcare.

Submissions

Stage II submission are now being accepted.

Deadline: Feb. 26, 2024

Submit today

The AMIA AI Evaluation Showcase Series aims to select and present the current use cases in the field and form a community to help build consensus around best practice. The community and the curated best practice examples are expected to strengthen the thought leadership position of the AMIA community in the industrial standard understanding and setting.

Three Stages

Upcoming Submissions

Stage II - Usability and Workflow Studies

Deadline: February 26, 2024

Submission to address usability and workflow aspects of the AI system, including prototype usability or satisfaction, algorithm explainability, implementation lessons, and/or system use in context.

View the abstract template

Helpful resources for submissions and presentations

 

Stage III - Health Impact Studies

Deadline: August 2, 2024

In Stage III, we will invite submissions for projects to summarize the comprehensive evaluation of the Health AI implementation – from the Stage I results of technical model performance (including bias detection and mitigation) to the Stage II results of workflow/usability studies to new research results in Stage III that measure the impact of the AI implementation. Authors should report on the impacts of the AI implementation based on the measures of their choice, e.g., clinical outcomes, patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), clinician experience and adoption measures, cost of care, healthcare quality, or other measures from health economic studies.

Those who did not submit for Stage I and Stage II but still wish to participate in Stage III should follow the Stage I and Stage II submission guidelines to include the evaluation plan for all three stages and the result for all three stages. The best work will be considered for publication in JAMIA Open.

If your organization has AI/ML initiatives or departments, please help pass the CFP to your colleagues involved in those initiatives and departments. This year, we would like to extend our invitation to submit to our industrial partners who have been working in this area to join this ecosystem too. We would like to start the conversations in the community and collect best practice examples. Your help would be highly appreciated.

Past Submissions

Stage I - Technical Performance Studies

Deadline: February 5, 2024

Stage I of the AMIA AI Evaluation Showcase calls for the submission of a uniform preliminary abstract for all submission types. Submissions accepted for oral presentation will be invited to submit a podium abstract or paper, author’s choice. No further action will be required for the poster submission type.

View the abstract template

Helpful resources for submissions and presentations

Submission to have a system description, results from a study of AI/ML model performance, and a brief outline of the methods of the full evaluation plan (for Stages II and III). For the evaluation of model performance, teams are encouraged to report on the evaluation metrics that would be useful to assess not only the model’s discrimination ability but also its reliability in different settings. We strongly encourage teams to report on their bias detection and mitigation strategy.

Stage Overview

Stage I - Technical Performance Studies Stage II - Usability and Workflow Studies Stage III - Health Impact Studies
Submission to have a system description, results from a study of algorithm performance, and an outline of the methods of the full evaluation plan. Submission to address usability and workflow aspects of the AI system, including prototype usability or satisfaction, algorithm explainability, implementation lessons, and/or system use in context. Submissions to summarize the comprehensive evaluation to include research from prior submissions with new research results that measure the impact of the tool; acceptance of stage II submission not required.

Informatics Summit: March 18-21, 2024, Boston, MA

Clinical Informatics Conference, May 21-23, 2024, Minneapolis, MN

AMIA Annual Symposium, November 9-13, 2024, San Francisco, CA

Deadline: Closed

Deadline: Feb. 26, 2024

Deadline: Aug. 2, 2024

 

How to Participate

Select a Team and Team Leads

Scientific teams must commit to submitting work centered around the same solution to all three conferences and should designate a lead scientist for the team. Given the different nature of each conference and the types of expertise needed for each stage, authorship is expected to vary for each submission.

Determine Type of Submission

AMIA offers three ways to participate: submitting a paper, podium abstract, and poster proposals for Stage I and II deadlines. We envision submitting a final proposal providing a summary of the entire evaluation, in paper or podium abstract format.

We will attempt to give those scientists committing to and completing comprehensive evaluations to present at the various meetings. For all meetings, scientifically rigorous manuscripts and podium abstracts not incorporated into a scientific session will receive a poster presentation opportunity.

Journal Publications

We are in discussion with an informatics journal for publishing the selected papers via a specific issue. The selected work will receive a publication opportunity subject to the peer-review process.

Who Can Submit to the AI Showcase

Domestic and international contributions to the showcase are welcome from AMIA members, non-members, and students from all informatics sectors. A separate Scientific Program Committee (SPC) will judge proposals and select presentations for a series of sessions and posters at the Informatics Summit, Clinical Informatics Conference, and Annual Symposium.

Questions?

Please review the updated FAQs.

Scientific Program Committee (SPC) 

Fuchiang (Rich) Tsui, PhD, FAMIA, IEEE Senior Member
Endowed Chair, Associate Professor
Children’s Hospital of Philadelphia and University of Pennsylvania
Eileen Koski, MPhil, FAMIA
Vice Chair, Data Science/Artificial Intelligence
IBM Research, Healthcare and Life Sciences
Shauna M Overgaard, MHI, PhD
Enterprise AI Evaluation and Global Partnership Strategy
Mayo Clinic

Meet the full scientific program committee

JAMIA Open

Call for Papers

JAMIA Open Special Issue: Health AI Evaluation Showcase

Submission Deadline: rolling basis until April 1, 2024

Learn more

Gretchen-Purcell-Jackson

Gretchen Purcell Jackson, MD, PhD, FACS, FACMI, FAMIA

I am especially passionate about systematic and comprehensive evaluation of AI tools to ensure they can be safely and effectively deployed in healthcare settings. Such evaluation includes studies of technical performance, usability and workflow, and health impact. The AMIA 2022 Artificial Intelligence Evaluation Showcase is AMIA’s contribution to encourage comprehensive AI evaluation to address this gap.

Fellow 2022 AMIA Scientific Program Committee (SPC) Chairs Laura Wiley (Informatics Summit), Rosemary Kennedy and Paul Fu (Clinical Informatics Conference) and I collaborated to create this first-of-its-kind cross-meeting AMIA program.

The goal is to produce content featuring the individual components of comprehensive AI evaluation through AMIA’s three major conferences.

Informatics is a team sport and this is a great opportunity for scientific teams to showcase their research accomplishments in the exciting world of AI in healthcare.

Questions?

If you are interested in or have questions about this opportunity, please contact Jeff Williamson, Vice President of Education and Academic Affairs.